Fixed and flexible formularies as cost-control mechanisms

Research output: Contribution to journalReview article

5 Citations (Scopus)

Abstract

The purpose of this review is to consider the prevalent types of fixed and flexible formularies, the general economic principles on which they are based and the evidence for their effectiveness in controlling rising drug expenditures. The principal-agent relationship and economic model underlying the various types of formularies are described. The principal-agent model describes a relationship where there is an asymmetry of information between two parties involved in a particular task. As a result of this asymmetry of information, the party with less information (the principal) allows the party with more information (the agent) to make decisions about that task or activity for them. In the case of formularies and cost-control, the principal is the payer. Depending on the incentives offered by the formulary, the agent can alternately be the prescriber, dispenser or patient. The success of a formulary type to control costs is dependent on two main factors. First, the payer (the principal) must identify the agent for whom it is reasonable to create incentives that incorporate the financial risks associated with use of the drugs. Second, the payer must develop a structure that best aligns the principal and agent objectives. The principal-agent framework serves as the vehicle through which the authors examine five major types of formularies (i.e., closed, best available price, reference-based pricing, tiered and open formularies) and their inherent incentives and limitations. The evidence for their effectiveness as cost-control mechanisms is reviewed and the system factors that can affect formulary success will be discussed. Finaly, the authors' observations are summarized and interpreted, and suggested implications for future use of formularies in controlling the costs of pharmaceutical use are offered.

Original languageEnglish (US)
Pages (from-to)303-315
Number of pages13
JournalExpert Review of Pharmacoeconomics and Outcomes Research
Volume3
Issue number3
DOIs
StatePublished - Jun 2003
Externally publishedYes

Fingerprint

Formularies
Cost Control
Motivation
Pharmaceutical Preparations
Economic Models
Costs and Cost Analysis
Health Expenditures
Economics

Keywords

  • Cost-containment
  • Fixed formulary
  • Flexible formulary
  • Prescription drug benefits

ASJC Scopus subject areas

  • Pharmacology
  • Medicine (miscellaneous)

Cite this

Fixed and flexible formularies as cost-control mechanisms. / Dewa, Carolyn S; Hoch, Jeffrey S.

In: Expert Review of Pharmacoeconomics and Outcomes Research, Vol. 3, No. 3, 06.2003, p. 303-315.

Research output: Contribution to journalReview article

@article{4c35127217e445f8bf61d65e2290c9fe,
title = "Fixed and flexible formularies as cost-control mechanisms",
abstract = "The purpose of this review is to consider the prevalent types of fixed and flexible formularies, the general economic principles on which they are based and the evidence for their effectiveness in controlling rising drug expenditures. The principal-agent relationship and economic model underlying the various types of formularies are described. The principal-agent model describes a relationship where there is an asymmetry of information between two parties involved in a particular task. As a result of this asymmetry of information, the party with less information (the principal) allows the party with more information (the agent) to make decisions about that task or activity for them. In the case of formularies and cost-control, the principal is the payer. Depending on the incentives offered by the formulary, the agent can alternately be the prescriber, dispenser or patient. The success of a formulary type to control costs is dependent on two main factors. First, the payer (the principal) must identify the agent for whom it is reasonable to create incentives that incorporate the financial risks associated with use of the drugs. Second, the payer must develop a structure that best aligns the principal and agent objectives. The principal-agent framework serves as the vehicle through which the authors examine five major types of formularies (i.e., closed, best available price, reference-based pricing, tiered and open formularies) and their inherent incentives and limitations. The evidence for their effectiveness as cost-control mechanisms is reviewed and the system factors that can affect formulary success will be discussed. Finaly, the authors' observations are summarized and interpreted, and suggested implications for future use of formularies in controlling the costs of pharmaceutical use are offered.",
keywords = "Cost-containment, Fixed formulary, Flexible formulary, Prescription drug benefits",
author = "Dewa, {Carolyn S} and Hoch, {Jeffrey S}",
year = "2003",
month = "6",
doi = "10.1586/14737167.3.3.303",
language = "English (US)",
volume = "3",
pages = "303--315",
journal = "Expert Review of Pharmacoeconomics and Outcomes Research",
issn = "1473-7167",
publisher = "Expert Reviews Ltd.",
number = "3",

}

TY - JOUR

T1 - Fixed and flexible formularies as cost-control mechanisms

AU - Dewa, Carolyn S

AU - Hoch, Jeffrey S

PY - 2003/6

Y1 - 2003/6

N2 - The purpose of this review is to consider the prevalent types of fixed and flexible formularies, the general economic principles on which they are based and the evidence for their effectiveness in controlling rising drug expenditures. The principal-agent relationship and economic model underlying the various types of formularies are described. The principal-agent model describes a relationship where there is an asymmetry of information between two parties involved in a particular task. As a result of this asymmetry of information, the party with less information (the principal) allows the party with more information (the agent) to make decisions about that task or activity for them. In the case of formularies and cost-control, the principal is the payer. Depending on the incentives offered by the formulary, the agent can alternately be the prescriber, dispenser or patient. The success of a formulary type to control costs is dependent on two main factors. First, the payer (the principal) must identify the agent for whom it is reasonable to create incentives that incorporate the financial risks associated with use of the drugs. Second, the payer must develop a structure that best aligns the principal and agent objectives. The principal-agent framework serves as the vehicle through which the authors examine five major types of formularies (i.e., closed, best available price, reference-based pricing, tiered and open formularies) and their inherent incentives and limitations. The evidence for their effectiveness as cost-control mechanisms is reviewed and the system factors that can affect formulary success will be discussed. Finaly, the authors' observations are summarized and interpreted, and suggested implications for future use of formularies in controlling the costs of pharmaceutical use are offered.

AB - The purpose of this review is to consider the prevalent types of fixed and flexible formularies, the general economic principles on which they are based and the evidence for their effectiveness in controlling rising drug expenditures. The principal-agent relationship and economic model underlying the various types of formularies are described. The principal-agent model describes a relationship where there is an asymmetry of information between two parties involved in a particular task. As a result of this asymmetry of information, the party with less information (the principal) allows the party with more information (the agent) to make decisions about that task or activity for them. In the case of formularies and cost-control, the principal is the payer. Depending on the incentives offered by the formulary, the agent can alternately be the prescriber, dispenser or patient. The success of a formulary type to control costs is dependent on two main factors. First, the payer (the principal) must identify the agent for whom it is reasonable to create incentives that incorporate the financial risks associated with use of the drugs. Second, the payer must develop a structure that best aligns the principal and agent objectives. The principal-agent framework serves as the vehicle through which the authors examine five major types of formularies (i.e., closed, best available price, reference-based pricing, tiered and open formularies) and their inherent incentives and limitations. The evidence for their effectiveness as cost-control mechanisms is reviewed and the system factors that can affect formulary success will be discussed. Finaly, the authors' observations are summarized and interpreted, and suggested implications for future use of formularies in controlling the costs of pharmaceutical use are offered.

KW - Cost-containment

KW - Fixed formulary

KW - Flexible formulary

KW - Prescription drug benefits

UR - http://www.scopus.com/inward/record.url?scp=0038680398&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0038680398&partnerID=8YFLogxK

U2 - 10.1586/14737167.3.3.303

DO - 10.1586/14737167.3.3.303

M3 - Review article

C2 - 19807378

AN - SCOPUS:0038680398

VL - 3

SP - 303

EP - 315

JO - Expert Review of Pharmacoeconomics and Outcomes Research

JF - Expert Review of Pharmacoeconomics and Outcomes Research

SN - 1473-7167

IS - 3

ER -